(714) 677-2145
Tue - Sat: 8:00 AM - 5:00 PM

Accelerate Pharma Part 2: Transforming Value in the Pharmaceutical Industry | The Dyson Blog

Time: 2025-10-08 22:00:44 Source: Author: Best Luggage

It’s so inspirational.’.

HH: I think there’s a massive push at the moment for battery technology, as a very specific example.There’s been a general realisation that there’s not enough power in the world, so people are looking into the likes of local generation.

Accelerate Pharma Part 2: Transforming Value in the Pharmaceutical Industry | The Dyson Blog

I also feel there’s a big issue around the embodied carbon that goes into making a battery and how batteries are reused and recycled.As such, there’s going to be quite a distinct focus on looking at some of the new technologies and working out whether they are actually going to be suitable in another fifty years time..I also think there will be a huge drive to reduce material quantity in buildings.

Accelerate Pharma Part 2: Transforming Value in the Pharmaceutical Industry | The Dyson Blog

As a result, there will be less carbon going into the building and the lifecycle impact of the building will be lower.I don’t believe this is necessarily achievable just by changing materials.

Accelerate Pharma Part 2: Transforming Value in the Pharmaceutical Industry | The Dyson Blog

You’ll also need to look at reducing the quantity of materials and their transportation distances, as well as other similar considerations.. IP: What one piece of advice would you give to an architecture student about how to deliver sustainable design?.

HH: Listen to your sustainability team.Detailed design outputs for manufacturing can be produced automatically.

The review and approval process is simplified dramatically.Safety related and non-safety related systems are separated and simplified.

The amount of information to be reviewed is significantly reduced.Standardised solutions mean that detail is available early and can be pre-approved.

(Editor: Eco Sofas)